Primary and metastatic peritoneal surface malignancies
Peritoneal surface malignancies comprise a heterogeneous group of primary tumours,
including peritoneal mesothelioma, and peritoneal metastases of other tumours, including …
including peritoneal mesothelioma, and peritoneal metastases of other tumours, including …
CA125 and ovarian cancer: a comprehensive review
Simple Summary CA125 has been the most promising biomarker for screening ovarian
cancer; however, it still does not have an acceptable accuracy in population-based …
cancer; however, it still does not have an acceptable accuracy in population-based …
Cancer-erythrocyte hybrid membrane-camouflaged magnetic nanoparticles with enhanced photothermal-immunotherapy for ovarian cancer
J Xiong, M Wu, J Chen, Y Liu, Y Chen, G Fan, Y Liu… - ACS …, 2021 - ACS Publications
Cell-membrane-coated nanoparticles are widely studied due to their inherent cellular
properties, such as immune escape and homologous homing. A cell membrane coating can …
properties, such as immune escape and homologous homing. A cell membrane coating can …
Epithelial ovarian cancer: evolution of management in the era of precision medicine
S Lheureux, M Braunstein… - CA: a cancer journal for …, 2019 - Wiley Online Library
Ovarian cancer is the second most common cause of gynecologic cancer death in women
around the world. The outcomes are complicated, because the disease is often diagnosed …
around the world. The outcomes are complicated, because the disease is often diagnosed …
Longitudinal single-cell RNA-seq analysis reveals stress-promoted chemoresistance in metastatic ovarian cancer
Chemotherapy resistance is a critical contributor to cancer mortality and thus an urgent
unmet challenge in oncology. To characterize chemotherapy resistance processes in high …
unmet challenge in oncology. To characterize chemotherapy resistance processes in high …
Worldwide burden, risk factors, and temporal trends of ovarian cancer: a global study
Simple Summary Ovarian cancer was the third most common gynecological cancer globally
in 2020. Ovarian carcinoma is the most common type of ovarian cancer, comprising over …
in 2020. Ovarian carcinoma is the most common type of ovarian cancer, comprising over …
[HTML][HTML] Recent advancement in cancer detection using machine learning: Systematic survey of decades, comparisons and challenges
T Saba - Journal of infection and public health, 2020 - Elsevier
Cancer is a fatal illness often caused by genetic disorder aggregation and a variety of
pathological changes. Cancerous cells are abnormal areas often growing in any part of …
pathological changes. Cancerous cells are abnormal areas often growing in any part of …
[HTML][HTML] Updates and new options in advanced epithelial ovarian cancer treatment
Financial Disclosure Ernst Lengyel disclosed that money was paid to his institution from
AbbVie (funding preclinical studies), NCI (RO1 grants), and the Ovarian Cancer Research …
AbbVie (funding preclinical studies), NCI (RO1 grants), and the Ovarian Cancer Research …
[HTML][HTML] PARP inhibition promotes ferroptosis via repressing SLC7A11 and synergizes with ferroptosis inducers in BRCA-proficient ovarian cancer
Pharmacologic inhibition of PARP is the primary therapeutic strategy for BRCA mutant
ovarian cancer. However, most of patients carry wild-type BRCA1/2 with no significant …
ovarian cancer. However, most of patients carry wild-type BRCA1/2 with no significant …
Immunotherapy for ovarian cancer: adjuvant, combination, and neoadjuvant
C Yang, BR Xia, ZC Zhang, YJ Zhang, G Lou… - Frontiers in …, 2020 - frontiersin.org
Ovarian cancer is the most lethal gynecologic malignancy. Surgery and chemotherapy are
the primary treatments for ovarian cancer; however, patients often succumb to recurrence …
the primary treatments for ovarian cancer; however, patients often succumb to recurrence …